Cited by

• Tissue acylcarnitine status in a mouse model of mitochondrial β-oxidation deficiency during metabolic decompensation due to influenza virus infection.

  Tarasenko TN, Cusmano-Ozog K, McGuire PJ. Tarasenko TN, et al. Mol Genet Metab. 2018 Sep;125(1-2):144-152. doi: 10.1016/j.ymgme.2018.06.012. Epub 2018 Jun 23. Mol Genet Metab. 2018. PMID: 30031688 Free PMC article.
• Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle.

  Knottnerus SJG, Bleeker JC, Wüst RCI, Ferdinandusse S, IJlst L, Wijburg FA, Wanders RJA, Visser G, Houtkooper RH. Knottnerus SJG, et al. Rev Endocr Metab Disord. 2018 Mar;19(1):93-106. doi: 10.1007/s11154-018-9448-1. Rev Endocr Metab Disord. 2018. PMID: 29926323 Free PMC article. Review.
• Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.

  Diekman EF, Ferdinandusse S, van der Pol L, Waterham HR, Ruiter JP, Ijlst L, Wanders RJ, Houten SM, Wijburg FA, Blank AC, Asselbergs FW, Houtkooper RH, Visser G. Diekman EF, et al. Genet Med. 2015 Dec;17(12):989-94. doi: 10.1038/gim.2015.22. Epub 2015 Apr 2. Genet Med. 2015. PMID: 25834949
• Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database.

  Pena LD, van Calcar SC, Hansen J, Edick MJ, Walsh Vockley C, Leslie N, Cameron C, Mohsen AW, Berry SA, Arnold GL, Vockley J; IBEMC. Pena LD, et al. Mol Genet Metab. 2016 Aug;118(4):272-81. doi: 10.1016/j.ymgme.2016.05.007. Epub 2016 May 13. Mol Genet Metab. 2016. PMID: 27209629 Free PMC article.
• Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders.

  Sklirou E, Alodaib AN, Dobrowolski SF, Mohsen AA, Vockley J. Sklirou E, et al. Front Genet. 2021 Jan 15;11:598760. doi: 10.3389/fgene.2020.598760. eCollection 2020. Front Genet. 2021. PMID: 33584796 Free PMC article.